Medtronic

Clinical study conducted on revision subjects supports expanded indication for patients with previously surgically altered tissue

Acquisition fits Medtronic’s bill perfectly as it enhances the heart failure portfolio

Medtronic says the benefits of its new cervical spinal fusion systems lies in reducing sterilization requirements

Medtronic’s Micra® TPS is the first transcatheter pacemaker to be approved in the U.S., giving patients access to the most advanced pacing technology at one-tenth the size of traditional devices

NURO™ is a minimally invasive nerve stimulation system delivering therapy over 12 weeks and offering long term relief

Extensive study will investigate whether promising clinical results translate into a real world clinical setting

Medtonic is now able to offer both 1.5 and 3 Tesla indications for MR-Conditional ICMs, Pacemakers, ICDs and CRT-Ds

Aiming, as it does, at delivering comprehensive care solutions, Medtronic sets sights on ESRD market dominance

Cooled RF Ablation system targets pain reduction in resection of spinal metastases

Yet another acquisition as Medtronic bolts laryngoscope onto its airways portfolio

Medtronic is taking connectivity to a new level with its newly FDA approved cardiac device monitoring system

Data demonstrates value of Medtronic’s Integrated Pulmonary Index™ and Microstream™ Capnography

Medtronic’s new ICDs enable physicians to manage patients at increased risk for stroke and heart failure

Discreet, wireless touchscreen system allows for shorter evaluation of potential for long-term restoration of bladder or bowel function

Company aims at global standard of care in diagnosis of peripheral lung lesions

Not yet for sale in any market, Twelve’s TMVR system must have impressed the “Irish” titan enough to separate it from approaching half a billion dollars